Page 50 - e-book CPG - Bipolar Disorder

CLINICAL PRACTICE GUIDELINES MANAGEMENT OF BIPOLAR DISORDER (2ND ED.)

25. Hossain S, Mainali P, Bhimanadham NN, et al. Medical and Psychiatric Comorbidities in Bipolar
Disorder: Insights from National Inpatient Population-based Study. Cureus. 2019;11(9):e5636.
26. Yalin N, Conti I, Bagchi S, et al. Clinical characteristics and impacts of HIV infection in people
with bipolar disorders. J Affect Disord. 2021;294:794-801.
27. Yildiz A, Nikodem M, Vieta E, et al. A network meta-analysis on comparative efficacy and all-
cause discontinuation of antimanic treatments in acute bipolar mania. Psychol Med.
2015;45(2):299-317.
28. Kishi T, Ikuta T, Matsuda Y, et al. Mood stabilizers and/or antipsychotics for bipolar disorder in
the maintenance phase: a systematic review and network meta-analysis of randomized
controlled trials. Mol Psychiatry. 2021;26(8):4146-57.
29. Keramatian K, Chakrabarty T, Saraf G, et al. New Developments in the Use of Atypical
Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized
Controlled Trials. Curr Psychiatry Rep. 2021;23(7):39.
30. Fountoulakis KN, Tohen M, Zarate CA, Jr. Lithium treatment of Bipolar disorder in adults: A
systematic review of randomized trials and meta-analyses. Eur Neuropsychopharmacol.
2022;54:100-15.
31. Vieta E, Sachs G, Chang D, et al. Two randomized, double-blind, placebo-controlled trials and
one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania. J
Psychopharmacol. 2021;35(8):971-82.
32. Missio G, Moreno DH, Demetrio FN, et al. A randomized controlled trial comparing lithium plus
valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder:
the LICAVAL study. Trials. 2019;20(1):608.
33. Earley W, Durgam S, Lu K, et al. Tolerability of cariprazine in the treatment of acute bipolar I
mania: A pooled post hoc analysis of 3 phase II/III studies. J Affect Disord. 2017;215:205-12.
34. Bahji A, Ermacora D, Stephenson C, et al. Comparative efficacy and tolerability of
pharmacological treatments for the treatment of acute bipolar depression: A systematic review
and network meta-analysis. J Affect Disord. 2020;269:154-84.
35. Yildiz A, Siafis S, Mavridis D, et al. Comparative efficacy and tolerability of pharmacological
interventions for acute bipolar depression in adults: a systematic review and network meta-
analysis. Lancet Psychiatry. 2023;10(9):693-705.
36. Kadakia A, Dembek C, Heller V, et al. Efficacy and tolerability of atypical antipsychotics for acute
bipolar depression: a network meta-analysis. BMC Psychiatry. 2021;21(1):249.
37. Hu Y, Zhang H, Wang H, et al. Adjunctive antidepressants for the acute treatment of bipolar
depression: A systematic review and meta-analysis. Psychiatry Res. 2022;311:114468.
38. McGirr A, Vöhringer PA, Ghaemi SN, et al. Safety and efficacy of adjunctive second-generation
antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar
depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
Lancet Psychiatry. 2016;3(12):1138-46.
39. Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of
Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021;55(1):7-
117.
40. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments
(CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the
management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170.
41. Dean RL, Marquardt T, Hurducas C, et al. Ketamine and other glutamate receptor modulators for
depression in adults with bipolar disorder. Cochrane Database Syst Rev.
2021;10(10):CD011611.
42. Yatham LN, Chakrabarty T, Bond DJ, et al. Canadian Network for Mood and Anxiety Treatments
(CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the
management of patients with bipolar disorder with mixed presentations. Bipolar Disord.
2021;23(8):767-88.
43. Verdolini N, Hidalgo-Mazzei D, Murru A, et al. Mixed states in bipolar and major depressive
disorders: systematic review and quality appraisal of guidelines. Acta Psychiatr Scand.
2018;138(3):196-222.
44. McIntyre RS, Suppes T, Earley W, et al. Cariprazine efficacy in bipolar I depression with and
without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled
studies. CNS Spectr. 2020;25(4):502-10.
45. McIntyre RS, Durgam S, Huo J, et al. The Efficacy of Lumateperone in Patients With Bipolar
Depression With Mixed Features. J Clin Psychiatry. 2023;84(3).
36

36